4      0

Improvements in Itch-Related Quality of Life With Difelikefalin for Moderate-to-Severe Chronic Kidney Disease–Associated Pruritus: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies in Hemodialysis Patients

Credits: None available.


The participant will be able to describe efficacy of difelikefalin for improving itch-related quality of life in patients with moderate-to-severe chronic kidney disease‚Äďassociated pruritus



Credits: None available.

You must be logged in and own this session in order to post comments.